Spectral Medical Inc. (TSX:EDT)
1.340
0.00 (0.00%)
Nov 24, 2025, 9:46 AM EST
Spectral Medical Revenue
Spectral Medical had revenue of 675.00K CAD in the quarter ending September 30, 2025, with 34.46% growth. This brings the company's revenue in the last twelve months to 2.71M, up 34.85% year-over-year. In the year 2024, Spectral Medical had annual revenue of 2.29M with 43.05% growth.
Revenue (ttm)
2.71M
Revenue Growth
+34.85%
P/S Ratio
143.24
Revenue / Employee
93.28K
Employees
29
Market Cap
387.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.29M | 688.00K | 43.05% |
| Dec 31, 2023 | 1.60M | -69.00K | -4.14% |
| Dec 31, 2022 | 1.67M | -329.00K | -16.48% |
| Dec 31, 2021 | 2.00M | -105.00K | -5.00% |
| Dec 31, 2020 | 2.10M | -767.00K | -26.74% |
| Dec 31, 2019 | 2.87M | -972.00K | -25.31% |
| Dec 31, 2018 | 3.84M | 171.00K | 4.66% |
| Dec 31, 2017 | 3.67M | 124.00K | 3.50% |
| Dec 31, 2016 | 3.55M | 456.00K | 14.76% |
| Dec 31, 2015 | 3.09M | 125.00K | 4.22% |
| Dec 31, 2014 | 2.96M | 292.00K | 10.93% |
| Dec 31, 2013 | 2.67M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Trulieve Cannabis | 1.66B |
| Green Thumb Industries | 1.61B |
| Extendicare | 1.59B |
| WELL Health Technologies | 1.25B |
| Sienna Senior Living | 967.05M |
| Knight Therapeutics | 413.85M |
Spectral Medical News
- 16 days ago - Spectral Medical GAAP EPS of -$0.11, revenue of $0.6M - Seeking Alpha
- 7 weeks ago - Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF - GlobeNewsWire
- 2 months ago - Spectral Medical Announces Publication of EDEN Observational Study - GlobeNewsWire
- 2 months ago - Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, 2025 - GlobeNewsWire
- 3 months ago - Spectral Medical Receives US$3 Million From Vantive - GlobeNewsWire
- 3 months ago - Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock - GlobeNewsWire
- 3 months ago - Spectral Medical GAAP EPS of $0.00, revenue of $0.81M - Seeking Alpha
- 3 months ago - Spectral Medical Announces Second Quarter and Provides Corporate Update - GlobeNewsWire